Statins and the risks of stroke recurrence and death after ischemic stroke: the Fukuoka Stroke Registry.

[1]  S. Kihara,et al.  Other types of primary hyperlipoproteinemia(hyperlipidemia). Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version. , 2013, Journal of atherosclerosis and thrombosis.

[2]  T. Kitazono,et al.  Risk Score for Predicting Recurrence in Patients with Ischemic Stroke: The Fukuoka Stroke Risk Score for Japanese , 2012, Cerebrovascular Diseases.

[3]  A. Sicras-Mainar,et al.  Statins after recent stroke reduces recurrence and improves survival in an aging Mediterranean population without known coronary heart disease , 2012, Journal of clinical pharmacy and therapeutics.

[4]  J. Hata,et al.  Prestroke Glycemic Control Is Associated With the Functional Outcome in Acute Ischemic Stroke: The Fukuoka Stroke Registry , 2011, Stroke.

[5]  Yasuhiko Tomino,et al.  Revised equations for estimated GFR from serum creatinine in Japan. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  A. Kyritsis,et al.  Statin therapy after first stroke reduces 10-year stroke recurrence and improves survival , 2009, Neurology.

[7]  P. Amarenco,et al.  Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention , 2009, The Lancet Neurology.

[8]  M. Hennerici,et al.  Effects of Intense Low-Density Lipoprotein Cholesterol Reduction in Patients With Stroke or Transient Ischemic Attack: The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial , 2007, Stroke.

[9]  T. Funahashi,et al.  Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. , 2007, Journal of atherosclerosis and thrombosis.

[10]  J. Liao.  Safety and efficacy of statins in Asians. , 2007, The American journal of cardiology.

[11]  L. Goldstein,et al.  High-dose atorvastatin after stroke or transient ischemic attack. , 2006 .

[12]  J. Ferrières,et al.  Prognosis at 6 Months for Coronary and Cerebrovascular Patients: Impact of Antiplatelet Agents and Statins: Results from the Prevenir III Study , 2006, Cardiovascular Drugs and Therapy.

[13]  P. Touboul,et al.  Statins in Stroke Prevention and Carotid Atherosclerosis: Systematic Review and Up-to-Date Meta-Analysis , 2004, Stroke.

[14]  Y. Matsuzawa,et al.  Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease: secondary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT). , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[15]  Y. Matsuzawa,et al.  Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[16]  M. Weinstein,et al.  Long-term persistence in use of statin therapy in elderly patients. , 2002, JAMA.

[17]  J. Tu,et al.  Adherence With Statin Therapy in Elderly Patients With and Without Acute Coronary Syndromes , 2002 .

[18]  C. Ting,et al.  A randomized, double-blind, placebo-controlled, 8-week study to evaluate the efficacy and safety of once daily atorvastatin (10 mg) in patients with elevated LDL-cholesterol. , 2001, Japanese heart journal.

[19]  B. Tomlinson,et al.  Short‐Term Safety and Efficacy of Low‐Dose Simvastatin in Elderly Patients with Hypertensive Hypercholesterolemia and Fasting Hyperinsulinemia , 1997, Journal of clinical pharmacology.

[20]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[21]  P. Arora,et al.  Statin therapy in stroke prevention: a meta-analysis involving 121,000 patients. , 2008, The American journal of medicine.

[22]  K. Welch,et al.  High-dose atorvastatin after stroke or transient ischemic attack. , 2006, The New England journal of medicine.

[23]  Y. Goto,et al.  Randomized dose-response study of rosuvastatin in Japanese patients with hypercholesterolemia. , 2003, Journal of atherosclerosis and thrombosis.